Copyright Reports & Markets. All rights reserved.

Global Renal Disease Treatment Market Size, Status and Forecast 2019-2025

Request for Sample of this report
Buy now

Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Key Market Segments
    • 1.3 Players Covered
    • 1.4 Market Analysis by Type
      • 1.4.1 Global Renal Disease Treatment Market Size Growth Rate by Type (2014-2025)
      • 1.4.2 Acute Kidney Problems
      • 1.4.3 Chronic Kidney Diseases
      • 1.4.4 Others
    • 1.5 Market by Application
      • 1.5.1 Global Renal Disease Treatment Market Share by Application (2014-2025)
      • 1.5.2 Hospital
      • 1.5.3 Clinic
      • 1.5.4 Research Center
      • 1.5.5 Other
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Global Growth Trends

    • 2.1 Renal Disease Treatment Market Size
    • 2.2 Renal Disease Treatment Growth Trends by Regions
      • 2.2.1 Renal Disease Treatment Market Size by Regions (2014-2025)
      • 2.2.2 Renal Disease Treatment Market Share by Regions (2014-2019)
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers
      • 2.3.3 Market Opportunities

    3 Market Share by Key Players

    • 3.1 Renal Disease Treatment Market Size by Manufacturers
      • 3.1.1 Global Renal Disease Treatment Revenue by Manufacturers (2014-2019)
      • 3.1.2 Global Renal Disease Treatment Revenue Market Share by Manufacturers (2014-2019)
      • 3.1.3 Global Renal Disease Treatment Market Concentration Ratio (CR5 and HHI)
    • 3.2 Renal Disease Treatment Key Players Head office and Area Served
    • 3.3 Key Players Renal Disease Treatment Product/Solution/Service
    • 3.4 Date of Enter into Renal Disease Treatment Market
    • 3.5 Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Type and Application

    • 4.1 Global Renal Disease Treatment Market Size by Type (2014-2019)
    • 4.2 Global Renal Disease Treatment Market Size by Application (2014-2019)

    5 United States

    • 5.1 United States Renal Disease Treatment Market Size (2014-2019)
    • 5.2 Renal Disease Treatment Key Players in United States
    • 5.3 United States Renal Disease Treatment Market Size by Type
    • 5.4 United States Renal Disease Treatment Market Size by Application

    6 Europe

    • 6.1 Europe Renal Disease Treatment Market Size (2014-2019)
    • 6.2 Renal Disease Treatment Key Players in Europe
    • 6.3 Europe Renal Disease Treatment Market Size by Type
    • 6.4 Europe Renal Disease Treatment Market Size by Application

    7 China

    • 7.1 China Renal Disease Treatment Market Size (2014-2019)
    • 7.2 Renal Disease Treatment Key Players in China
    • 7.3 China Renal Disease Treatment Market Size by Type
    • 7.4 China Renal Disease Treatment Market Size by Application

    8 Japan

    • 8.1 Japan Renal Disease Treatment Market Size (2014-2019)
    • 8.2 Renal Disease Treatment Key Players in Japan
    • 8.3 Japan Renal Disease Treatment Market Size by Type
    • 8.4 Japan Renal Disease Treatment Market Size by Application

    9 Southeast Asia

    • 9.1 Southeast Asia Renal Disease Treatment Market Size (2014-2019)
    • 9.2 Renal Disease Treatment Key Players in Southeast Asia
    • 9.3 Southeast Asia Renal Disease Treatment Market Size by Type
    • 9.4 Southeast Asia Renal Disease Treatment Market Size by Application

    10 India

    • 10.1 India Renal Disease Treatment Market Size (2014-2019)
    • 10.2 Renal Disease Treatment Key Players in India
    • 10.3 India Renal Disease Treatment Market Size by Type
    • 10.4 India Renal Disease Treatment Market Size by Application

    11 Central & South America

    • 11.1 Central & South America Renal Disease Treatment Market Size (2014-2019)
    • 11.2 Renal Disease Treatment Key Players in Central & South America
    • 11.3 Central & South America Renal Disease Treatment Market Size by Type
    • 11.4 Central & South America Renal Disease Treatment Market Size by Application

    12 International Players Profiles

    • 12.1 Abbott
      • 12.1.1 Abbott Company Details
      • 12.1.2 Company Description and Business Overview
      • 12.1.3 Renal Disease Treatment Introduction
      • 12.1.4 Abbott Revenue in Renal Disease Treatment Business (2014-2019)
      • 12.1.5 Abbott Recent Development
    • 12.2 Amgen
      • 12.2.1 Amgen Company Details
      • 12.2.2 Company Description and Business Overview
      • 12.2.3 Renal Disease Treatment Introduction
      • 12.2.4 Amgen Revenue in Renal Disease Treatment Business (2014-2019)
      • 12.2.5 Amgen Recent Development
    • 12.3 Baxter
      • 12.3.1 Baxter Company Details
      • 12.3.2 Company Description and Business Overview
      • 12.3.3 Renal Disease Treatment Introduction
      • 12.3.4 Baxter Revenue in Renal Disease Treatment Business (2014-2019)
      • 12.3.5 Baxter Recent Development
    • 12.4 Bristol-Myers Squibb Company
      • 12.4.1 Bristol-Myers Squibb Company Company Details
      • 12.4.2 Company Description and Business Overview
      • 12.4.3 Renal Disease Treatment Introduction
      • 12.4.4 Bristol-Myers Squibb Company Revenue in Renal Disease Treatment Business (2014-2019)
      • 12.4.5 Bristol-Myers Squibb Company Recent Development
    • 12.5 Keryx Biopharmaceuticals
      • 12.5.1 Keryx Biopharmaceuticals Company Details
      • 12.5.2 Company Description and Business Overview
      • 12.5.3 Renal Disease Treatment Introduction
      • 12.5.4 Keryx Biopharmaceuticals Revenue in Renal Disease Treatment Business (2014-2019)
      • 12.5.5 Keryx Biopharmaceuticals Recent Development
    • 12.6 NephroGenex
      • 12.6.1 NephroGenex Company Details
      • 12.6.2 Company Description and Business Overview
      • 12.6.3 Renal Disease Treatment Introduction
      • 12.6.4 NephroGenex Revenue in Renal Disease Treatment Business (2014-2019)
      • 12.6.5 NephroGenex Recent Development
    • 12.7 Novartis AG
      • 12.7.1 Novartis AG Company Details
      • 12.7.2 Company Description and Business Overview
      • 12.7.3 Renal Disease Treatment Introduction
      • 12.7.4 Novartis AG Revenue in Renal Disease Treatment Business (2014-2019)
      • 12.7.5 Novartis AG Recent Development
    • 12.8 Pfizer
      • 12.8.1 Pfizer Company Details
      • 12.8.2 Company Description and Business Overview
      • 12.8.3 Renal Disease Treatment Introduction
      • 12.8.4 Pfizer Revenue in Renal Disease Treatment Business (2014-2019)
      • 12.8.5 Pfizer Recent Development
    • 12.9 Sanofi
      • 12.9.1 Sanofi Company Details
      • 12.9.2 Company Description and Business Overview
      • 12.9.3 Renal Disease Treatment Introduction
      • 12.9.4 Sanofi Revenue in Renal Disease Treatment Business (2014-2019)
      • 12.9.5 Sanofi Recent Development
    • 12.10 Shire Pharmaceuticals Limited
      • 12.10.1 Shire Pharmaceuticals Limited Company Details
      • 12.10.2 Company Description and Business Overview
      • 12.10.3 Renal Disease Treatment Introduction
      • 12.10.4 Shire Pharmaceuticals Limited Revenue in Renal Disease Treatment Business (2014-2019)
      • 12.10.5 Shire Pharmaceuticals Limited Recent Development
    • 12.11 CTI BioPharma Corp
    • 12.12 Merck
    • 12.13 Prolong Pharmaceuticals
    • 12.14 VESSL Therapeutics

    13 Market Forecast 2019-2025

    • 13.1 Market Size Forecast by Regions
    • 13.2 United States
    • 13.3 Europe
    • 13.4 China
    • 13.5 Japan
    • 13.6 Southeast Asia
    • 13.7 India
    • 13.8 Central & South America
    • 13.9 Market Size Forecast by Product (2019-2025)
    • 13.10 Market Size Forecast by Application (2019-2025)

    14 Analyst's Viewpoints/Conclusions

      15 Appendix

      • 15.1 Research Methodology
        • 15.1.1 Methodology/Research Approach
          • 15.1.1.1 Research Programs/Design
          • 15.1.1.2 Market Size Estimation
          • 12.1.1.3 Market Breakdown and Data Triangulation
        • 15.1.2 Data Source
          • 15.1.2.1 Secondary Sources
          • 15.1.2.2 Primary Sources
      • 15.2 Disclaimer

      In 2018, the global Renal Disease Treatment market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

      This report focuses on the global Renal Disease Treatment status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Renal Disease Treatment development in United States, Europe and China.

      The key players covered in this study
      Abbott
      Amgen
      Baxter
      Bristol-Myers Squibb Company
      Keryx Biopharmaceuticals
      NephroGenex
      Novartis AG
      Pfizer
      Sanofi
      Shire Pharmaceuticals Limited
      CTI BioPharma Corp
      Merck
      Prolong Pharmaceuticals
      VESSL Therapeutics

      Market segment by Type, the product can be split into
      Acute Kidney Problems
      Chronic Kidney Diseases
      Others

      Market segment by Application, split into
      Hospital
      Clinic
      Research Center
      Other

      Market segment by Regions/Countries, this report covers
      United States
      Europe
      China
      Japan
      Southeast Asia
      India
      Central & South America

      The study objectives of this report are:
      To analyze global Renal Disease Treatment status, future forecast, growth opportunity, key market and key players.
      To present the Renal Disease Treatment development in United States, Europe and China.
      To strategically profile the key players and comprehensively analyze their development plan and strategies.
      To define, describe and forecast the market by product type, market and key regions.

      In this study, the years considered to estimate the market size of Renal Disease Treatment are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025
      For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

      Buy now